Amrize (NYSE:AMRZ) Given New $57.00 Price Target at UBS Group

Amrize (NYSE:AMRZ) had its target price lifted by UBS Group from $53.00 to $57.00 in a research note released on Thursday morning,Benzinga reports. The firm currently has a neutral rating on the stock.

Other equities research analysts also recently issued research reports about the company. Wall Street Zen upgraded Amrize to a “hold” rating in a research report on Saturday, October 25th. Deutsche Bank Aktiengesellschaft set a $59.00 target price on Amrize in a research note on Monday, December 8th. Morgan Stanley set a $61.00 price target on Amrize and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Kepler Capital Markets raised Amrize to a “strong-buy” rating in a report on Tuesday, October 21st. Finally, Vertical Research began coverage on shares of Amrize in a research note on Tuesday, November 25th. They issued a “hold” rating and a $54.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $60.73.

Amrize Trading Up 1.6%

AMRZ stock opened at $55.30 on Thursday. The company has a 50 day moving average price of $52.53. The company has a market capitalization of $30.58 billion and a price-to-earnings ratio of 30.05. Amrize has a 12 month low of $44.12 and a 12 month high of $57.40. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.45 and a quick ratio of 0.97.

Amrize (NYSE:AMRZ) last posted its earnings results on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The company had revenue of $3.68 billion for the quarter, compared to analyst estimates of $3.49 billion. The business’s revenue for the quarter was up 6.6% on a year-over-year basis.

Insider Transactions at Amrize

In other news, Director Nicholas C. Gangestad bought 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 19th. The stock was bought at an average price of $47.34 per share, for a total transaction of $94,680.00. Following the transaction, the director directly owned 4,958 shares of the company’s stock, valued at $234,711.72. This represents a 67.61% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jaime Hill bought 4,000 shares of the business’s stock in a transaction on Tuesday, November 4th. The stock was purchased at an average cost of $50.69 per share, with a total value of $202,760.00. Following the purchase, the insider owned 18,101 shares of the company’s stock, valued at $917,539.69. This represents a 28.37% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders purchased 65,000 shares of company stock valued at $3,399,720.

Hedge Funds Weigh In On Amrize

Institutional investors and hedge funds have recently made changes to their positions in the business. State of Wyoming bought a new stake in Amrize in the third quarter worth $32,000. US Bancorp DE purchased a new position in shares of Amrize in the third quarter worth about $38,000. Costello Asset Management INC bought a new stake in shares of Amrize in the 3rd quarter valued at about $44,000. Global Retirement Partners LLC bought a new stake in shares of Amrize in the 3rd quarter valued at about $48,000. Finally, Jones Financial Companies Lllp purchased a new stake in Amrize during the 3rd quarter valued at about $53,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.